您的位置: 首页 > 农业专利 > 详情页

CONTINUOUS ADMINISTRATION OF CILENGITIDE IN CANCER TREATMENTS
专利权人:
Martin Andreas Picard;Ullrich Bethe;Matthias Dotzauer;Elizabeth Cohen-Jonathan Moyal
发明人:
Martin Andreas Picard,Ullrich Bethe,Matthias Dotzauer,Elizabeth Cohen-Jonathan Moyal
申请号:
US13322391
公开号:
US20120130146A1
申请日:
2010.05.25
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising the continuous administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agent or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充